Momelotinib reduces transfusion requirements in patients with myelofibrosis
- PMID: 35255234
- DOI: 10.1080/10428194.2022.2043304
Momelotinib reduces transfusion requirements in patients with myelofibrosis
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources